Role of endometriosis in cancer and tumor development

Annals of the New York Academy of Sciences

Volumn 955, Issue , 2002, Pages 281-292

  Swiersz, Lillian Marie ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Cancer; Endometriosis; Melanoma; Tumor development

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL INVASION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; GENETIC CODE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MELANOMA; NEOVASCULARIZATION (PATHOLOGY); OVARY CANCER;

FALLOPIA;

EID: 0036218164     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02788.x     Document Type: Conference Paper

References (45)

1. Prognostic importance of hyperplasia and atypia in endometriosis
2. Cancer risk after a hospital discharge diagnosis of endometriosis
3. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ
4. Malignant tumors arising in endometriosis
5. Endometriosis and ovarian cancer
6. Ovarian atypical endometriosis: Its close association with malignant epithelial tumours
7. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis
8. Histologic transformation of benign endometriosis to early epithelial ovarian cancer
9. Reduction in oocyte number following prenatal exposure to a diet high in galactose
10. Neoplastic diseases occurring among mice subjected to general irradiation with X rays
11. The induction of ovarian tumors in mice with 9,10-dimethyl 1,2-benzanthracene
12. Galactose consumption and metabolism in relation to the risk of ovarian cancer
13. Characteristics of women with a family history of ovarian cancer: I. Galactose consumption and metabolism
14. Vaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT)
15. Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT)
16. A case-control study of galactose consumption and metabolism in relation to ovarian cancer
17. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis
18. Milk consumption, galactose metabolism, and ovarian cancer (Australia)
19. Results of a survey of carrier women for the galactosemia gene
20. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases
21. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population
22. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis
23. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer
24. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci: Risk of ovarian cancer by histological subtype
25. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
26. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
27. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
28. PTEN gene mutations are seen in high-grade, but not in low-grade gliomas
29. PTEN/MMAC1 mutations in endometrial cancers
30. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
31. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
32. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
33. PTEN: Life as a tumor suppressor
34. The multiple roles of PTEN in tumor suppression
35. Frequent PTEN/MMAC mutations in endometrioid, but not serous or mucinous epithelial ovarian tumors
36. Common genetic changes between endometriosis and ovarian cancer
37. Heritability and molecular genetic studies of endometriosis
38. Molecular genetic defects in endometriosis
39. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary
40. Breast cancer risk in young women and history of selected medical conditions
41. Breast cancer risk associated with gynecologic surgery and indications for such surgery
42. Reproductive factors and melanoma of the skin among women
43. Dysplastic nevi, cutaneous melanoma, and gynecologic disorders
44. Association between endometriosis, dysplastic nevi, and history of melanoma in women of reproductive age
45. Cutaneous melanoma in women: III. Reproductive factors and oral contraceptive use